Gradient HPLC-DAD method for quantification of novel oral anticoagulant “Edoxaban” in plasma: Its selective determination in presence of sixteen co-administered drugs

Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography–tandem mass spectrometry

Cara Polson, Pratibha Sarkar, Bev Incledon et al. · Journal of Chromatography B · 2003 · 678 citations

Life Sciences, Biochemistry, Molecular Biology +16

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

Jeffrey L. Anderson, Joan R. Lutz, Edward M. Gilbert et al. · The American Journal of Cardiology · 1985 · 251 citations

Medicine, Cardiology, Pharmacology +7

Pharmacokinetics, Biotransformation, and Mass Balance of Edoxaban, a Selective, Direct Factor Xa Inhibitor, in Humans

Mohinder S. Bathala, Hiroshi Masumoto, Toshihiro Oguma et al. · Drug Metabolism and Disposition · 2012 · 190 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)- and S(-)-carvedilol.

Harriet G. Oldham, Stephen E. Clarke · PubMed · 1997 · 150 citations

Medicine, Biochemistry, Pharmacology +17

Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial

Robert P. Giugliano, Christian T. Ruff, Stephen D. Wiviott et al. · The American Journal of Medicine · 2016 · 74 citations · Full text

Medicine, Cardiology, Pharmacology +13